Save Form

Email Form to Student

AAMC Standardized Immunization Form
Clear Form
 
Middle
Last Name: First Name:
Initial:
DOB: Street Address:
Medical School: City:
Cell Phone: State:
Primary Email: ZIP Code:
Student ID: Last 4 SS#:

MMR (Measles, Mumps, Rubella) – 2 doses of MMR vaccine or two (2) doses of Measles, two (2) doses of Mumps and (1) dose of Rubella;
or serologic proof of immunity for Measles, Mumps and/or Rubella

Option1 Vaccine Date

MMR MMR Dose #1 ___/___/____

-2 doses of MMR vaccine MMR Dose #2 ___/___/____
Option 2 Vaccine or Test Date

Measles Vaccine Dose #1 ___/___/_____

Measles
-2 doses of vaccine or Measles Vaccine Dose #2 ___/___/_____
positive serology
Serologic Immunity (IgG, antibodies, titer) ___/___/_____  Copy Attached
Mumps Vaccine Dose #1 ___/___/_____
Mumps
-2 doses of vaccine or Mumps Vaccine Dose #2 ___/___/_____
positive serology
Serologic Immunity (IgG, antibodies, titer) ___/___/_____  Copy Attached
Rubella Rubella Vaccine ___/___/_____
-1 dose of vaccine or
positive serology Serologic Immunity (IgG, antibodies, titer) ___/___/_____  Copy Attached

Hepatitis B Vaccination --3 doses of vaccine followed by a QUANTITATIVE Hepatitis B Surface Antibody (titer) preferably drawn 4-8 weeks after 3rd dose.
If negative, complete a second Hepatitis B series followed by a repeat titer. If Hepatitis B Surface Antibody is negative after a secondary series, additional testing
including Hepatitis B Surface Antigen should be performed. See: http://www.cdc.gov/mmwr/pdf/rr/rr6210.pdf for more information.

Documentation of Chronic Active Hepatitis B is for rotation assignments and counseling purposes only.
Date
Hepatitis B Vaccine Dose #1 ___/___/_____

Primary Hepatitis B Vaccine Dose #2 ___/___/_____

Hepatitis B Series Hepatitis B Vaccine Dose #3 ___/___/_____
Result  Copy
QUANTITATIVE Hep B Surface Antibody ___/___/_____ _______ mIU/ml Attached

Hepatitis B Vaccine Dose #4 ___/___/_____

Hepatitis B Vaccine Dose #5 ___/___/_____
Secondary Hepatitis
B Series Hepatitis B Vaccine Dose #6 ___/___/_____
(If no response to primary series)
Result  Copy
QUANTITATIVE Hep B Surface Antibody ___/___/_____ _______ mIU/ml Attached
Hepatitis B Vaccine Hepatitis B Surface Antigen (if 2nd titer negative) ___/___/_____  Copy Attached
Non-responder
(If Hepatitis B Surface Antibody
Negative after Primary and Secondary Hepatitis B Core Antibody (if 2nd titer negative ) ___/___/_____  Copy Attached
Series)

Chronic Active Hepatitis B Surface Antigen ___/___/_____  Copy Attached

Hepatitis B Hepatitis B Viral Load ___/___/_____  Copy Attached

Tetanus-diphtheria-pertussis – One (1) dose of adult Tdap. If last Tdap is more than 10 years old, provide date of last Td and Tdap

Date
Tdap Vaccine (Adacel, Boostrix, etc) ___/___/_____

Td Vaccine (if more than 10 years since last Tdap) ___/___/_____

© 2015 AAMC. May be reproduced and distributed in its entirety, no modification, with attribution.      Page 1 of 3 
 
 

AAMC Standardized Immunization Form

Name: _____________________________________________________ Date of Birth: _________________
(Last, First, Middle Initial) (mm/dd/yyyy)

TUBERCULOSIS SCREENING – Results of last (2) TSTs (PPDs) or (1) IGRA blood test are required regardless of prior BCG
status. If you have a history of a positive TST (PPD)>10mm or IGRA please supply information regarding any evaluation and/or
treatment below. You only need to complete ONE section.

Skin test or IGRA results should not expire during proposed elective rotation dates
or
must be updated with the receiving institution prior to rotation.

Tuberculin Screening History 
Section A   Date Placed Date Read Reading Interpretation

TST #1 ___/___/____ ___/___/____ ____ mm  Pos  Neg  Equiv

TST #2  ___/___/____ ___/___/____ ____mm  Pos  Neg  Equiv 

Negative Skin or
Blood Test TST #3  ___/___/____ ___/___/____ ____ mm  Pos  Neg  Equiv 
History
Date Result
Please complete one TB section only

Last two skin test IGRA Blood Test  Negative

or IGRAs required (Interferon gamma releasing assay)
___/___/____  Indeterminate
 Copy Attached
Use additional
rows as needed
IGRA Blood Test  Negative
(Interferon gamma releasing assay)
___/___/____  Indeterminate
 Copy Attached

IGRA Blood Test  Negative

(Interferon gamma releasing assay)
___/___/____  Indeterminate
 Copy Attached

Section B Date Placed Date Read Reading Interpretation

Positive TST ___/___/____ ___/___/___ _____ mm
 

Date Result

History of Positive IGRA Blood Test ___/___/____ _____ IU  Copy Attached

Latent
Tuberculosis,
Chest X-ray ___/___/____  Copy Attached
Positive Skin
Test or
Positive Blood
Prophylactic Medications for latent TB taken?  Yes  No
Test Total Duration of prophylaxis? _____ Months

Date of Last Annual TB Symptom Questionnaire

(if applicable)
___/___/_____  Copy Attached

Section C Date
Date of Diagnosis ___/___/___ 
Date of Treatment Completed ___/___/____   Copy Attached
History of Active
Tuberculosis Date of Last Annual TB Symptom Questionnaire
(if applicable) ___/___/____   Copy Attached

Date of Last Chest X-ray ___/___/____   Copy Attached

Varicella (Chicken Pox) -2 doses of vaccine or positive serology

Date
Varicella Vaccine #1 ___/___/_____
Varicella Vaccine #2 ___/___/_____
Serologic Immunity (IgG, antibodies, titer) ___/___/_____  Copy Attached

© 2015 AAMC. May be reproduced and distributed in its entirety, no modification, with attribution.      Page 2 of 3 
  
 

AAMC Standardized Immunization Form

Name: _____________________________________________________ Date of Birth: _________________
(Last, First, Middle Initial) (mm/dd/yyyy)

Influenza Vaccine --1 dose annually each fall

Flu Vaccine ___/___/____  Copy Attached
Flu Vaccine ___/___/____  Copy Attached

Additional Information:

MUST BE COMPLETED BY YOUR HEALTH CARE PROVIDER OR INSTITUTIONAL REPRESENTATIVE:

Authorized Signature: Date: ___/___/____

Printed Name:
Office Use Only
Title:

Address Line 1:

Address Line 2:

City:

State:

Zip:

Phone: (____) ______-____________ Ext: _______

Fax: (____) ______-____________

Email Contact:

*Sources:   
1. Hepatitis B In:  Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine‐Preventable Diseases. Hamborsky J, Kroger A, Wolfe S, eds. 
13th ed. Washington D.C. Public Health Foundation, 2015 
2. Immunization of Health‐Care Personnel:  Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR, Vol 60(7):1‐45 
3. CDC Guidance for Evaluating Health‐Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management, MMWR, Vol 62(RR10):1‐19  
Save Form Email Form to Student Clear Form

© 2015 AAMC. May be reproduced and distributed in its entirety, no modification, with attribution.      Page 3 of 3